Login / Signup

Neovascular age-related macular degeneration at treatment intervals of 14 weeks or greater.

Elisa Eleanor CornishVuong NguyenStephanie YoungSamantha Fraser-BellRobyn H GuymerDavid SquirrellBarthelmes DanielMark C Gillies
Published in: Clinical & experimental ophthalmology (2021)
We found that only 10% of eyes with nAMD were extended beyond a 13-week injection interval and that over half had returned to a shorter interval by 12 months. Eyes that stayed at this extended treatment interval maintained stable vision. More data on the outcomes of eyes treated with intervals longer than 3 months are required to establish whether emerging VEGF inhibitors provide a more sustained effect than the currently available drugs.
Keyphrases
  • age related macular degeneration
  • optical coherence tomography
  • deep learning
  • data analysis